These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11935092)

  • 1. Gene therapy of hepatocellular carcinoma.
    Ruiz J; Mazzolini G; Sangro B; Qian C; Prieto J
    Dig Dis; 2001; 19(4):324-32. PubMed ID: 11935092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery approaches of gene therapy in hepatocellular carcinoma.
    Duan F; Lam MG
    Anticancer Res; 2013 Nov; 33(11):4711-8. PubMed ID: 24222105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of liver cancer.
    Hernandez-Alcoceba R; Sangro B; Prieto J
    World J Gastroenterol; 2006 Oct; 12(38):6085-97. PubMed ID: 17036377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy strategies for hepatocellular carcinoma.
    Hwang LH
    J Biomed Sci; 2006 Jul; 13(4):453-68. PubMed ID: 16633742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of viral hepatitis and hepatocellular carcinoma.
    Ruiz J; Qian C; Drozdzik M; Prieto J
    J Viral Hepat; 1999 Jan; 6(1):17-34. PubMed ID: 10847127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.
    Schepelmann S; Hallenbeck P; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Hay C; Hawkins LK; Marais R; Springer CJ
    Cancer Res; 2005 Jun; 65(12):5003-8. PubMed ID: 15958540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy of liver cancer.
    Hernández-Alcoceba R; Sangro B; Prieto J
    Ann Hepatol; 2007; 6(1):5-14. PubMed ID: 17297424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for malignant liver disease.
    Mohr L; Geissler M; Blum HE
    Expert Opin Biol Ther; 2002 Feb; 2(2):163-75. PubMed ID: 11849116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.
    Rodriguez-Madoz JR; Zabala M; Alfaro M; Prieto J; Kramer MG; Smerdou C
    Hum Gene Ther; 2014 Feb; 25(2):132-43. PubMed ID: 24219025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy of liver tumors].
    Panis Y; Charre L; Alves A; Soubrane O
    J Chir (Paris); 2000 Dec; 137(6):317-24. PubMed ID: 11119025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocellular carcinoma: novel therapeutic approaches].
    Mohr L
    Praxis (Bern 1994); 2007 Apr; 96(14):553-62. PubMed ID: 17455567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for liver metastases.
    Havlik R; Jiao LR; Nicholls J; Jensen SL; Habib NA
    Semin Oncol; 2002 Apr; 29(2):202-8. PubMed ID: 11951219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Approaches to gene therapy of hepatocellular carcinoma].
    Ameis D
    Internist (Berl); 2000 Feb; 41(2 Pt 2):208-12. PubMed ID: 10756437
    [No Abstract]   [Full Text] [Related]  

  • 16. New hope for a microRNA therapy for liver cancer.
    Rossi JJ
    Cell; 2009 Jun; 137(6):990-2. PubMed ID: 19524500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of gene therapy for hepatocellular carcinoma, with a focus on gene delivery approaches.
    Wang X; Tai Z; Zhang W; Gao S
    Curr Gene Ther; 2015; 15(2):120-41. PubMed ID: 25537775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for HCV/HBV-induced hepatocellular carcinoma.
    Smerdou C; Menne S; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1368-77. PubMed ID: 21154119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for liver cancer: clinical experience and future prospects.
    Sangro B; Prieto J
    Curr Opin Mol Ther; 2010 Oct; 12(5):561-9. PubMed ID: 20886388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in delivery vectors for gene therapy in liver cancer.
    Redd Bowman KE; Lu P; Vander Mause ER; Lim CS
    Ther Deliv; 2020 Jan; 11(1):833-850. PubMed ID: 31840560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.